Fate Therapeutics
Clinical trials sponsored by Fate Therapeutics, explained in plain language.
-
First-in-Human trial tests 'Ready-Made' cell therapy for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called FT825/ONO-8250 in adults with advanced solid tumors that have stopped responding to standard treatments. The therapy involves giving patients specially engineered immune cells designed to find and attack cancer c…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First human trial tests new cell therapy for devastating autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing the safety of an experimental cell therapy called FT819 for four serious autoimmune diseases: lupus, vasculitis, myositis, and scleroderma. Researchers will give FT819 to 244 participants aged 12-70 who have moderate to severe disease that hasn't…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New 'Off-the-Shelf' cancer therapy enters human testing for multiple advanced cancers
Disease control Recruiting nowThis early-stage study is testing FT836, a new type of 'off-the-shelf' CAR T-cell therapy, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how well the body tolerates FT836, which is given al…
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC